EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer

Cisplatin is one of the first-line platinum-based chemotherapeutic agents for treatment of many types of cancer, including ovary cancer. CTR1 (copper transporter 1), a transmembrane solute carrier transporter, has previously been shown to increase the cellular uptake and sensitivity of cisplatin. It...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xuemin, Jiang, Pan, Wang, Pengqi, Yang, Chung S., Wang, Xuerong, Feng, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416002/
https://www.ncbi.nlm.nih.gov/pubmed/25927922
http://dx.doi.org/10.1371/journal.pone.0125402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416002/
https://www.ncbi.nlm.nih.gov/pubmed/25927922
http://dx.doi.org/10.1371/journal.pone.0125402

Ejemplares similares